CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...Jun 30, 2023 · What happened. Shares of CymaBay Therapeutics ( CBAY -0.06%) were up more than 37% as of 11:15 a.m. ET on Friday. The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced ... Cymabay Therapeutics Inc stock is currently priced at $32.13, with a 24-hour trading volume of 24.78M. ... Cymabay Therapeutics Inc Stock (CBAY) Financials Data Cymabay Therapeutics Inc (CBAY) Net Income 2023. CBAY net income (TTM) was -$90.10 million for the quarter ending September 30, 2023, a +14.93% increase year-over-year.CymaBay Therapeutics Market Cap: 2.61B, Enterprise value: 762.95M, P/E: -7.31, PEG ratio: -1.54, EPS: -1.09, Revenue: N/A, EBITDA: -74.92M, Income: -106.15M ...CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... Realtime quote and/or trade prices are not sourced from all markets. CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... Feb 13, 2024 · Detailed statistics for CymaBay Therapeutics, Inc. (CBAY) stock, including valuation metrics, financial numbers, share information and more. ... Stock Price Statistics. The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The …Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 4 days ago · CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73 When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks...Shares of CBAY surged 25.8% on the acquisition news as the offer price represents 27% of the company’s closing share price as of Feb 9, 2024. Financial Terms of the AcquisitionReal stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Daniel Menold, Vice President, Finance of CymaBay Therapeutics Inc (NASDAQ:CBAY), has sold 10,000 shares of the company on January 16, 2024, according to a recent SEC Filing. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 8, 2023 · CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/6/23. Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial …CBAYNasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research. CYMABAY THERAPEUTICS, INC. (CBAY). 32.18. at close. -0.02 ...CymaBay Therapeutics, Inc. (CBAY) Stock Price, News, Quote & History - Yahoo Finance CymaBay Therapeutics, Inc. (CBAY) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W... CymaBay Therapeutics, Inc. (CBAY.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock CymaBay Therapeutics, Inc. | Nasdaq: CBAY | …Jan 14, 2024 · CBAY Historical Data. ... Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR ...Mar 28, 2023 · Shares of CymaBay Therapeutics Inc. (CBAY) have gained 11.4% over the past four weeks to close the last trading session at $8.73, but there could still be a solid upside left in the stock if short ...Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. apple; wise; Select a currency. USD. …2 days ago · The Cymabay Therapeutics Inc stock price fell by -0.279% on the last day (Tuesday, 13th Feb 2024) from $32.21 to $32.12. During the last trading day the stock fluctuated 0.374% from a day low at $32.09 to a day high of $32.21. The price has risen in 6 of the last 10 days and is up by 35.81% over the past 2 weeks. Feb 16, 2024 · Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037Based on 7 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $28.67 with a high forecast of $36.00 and a low forecast of $20.00. The average price target represents a 20.61% change from the last price of $23.77. Highest Price Target $36.00. Average Price Target $28.67. Feb 13, 2024 · Health Care Sector Update for 02/12/2024: GILD, CBAY, IONM, TTOO February 12, 2024 — 01:51 pm EST Written by MT Newswires for MTNewswires ->CBAY enters Uptrend as Momentum indicator ascends above 0 level This indicator may be signaling that CBAY's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. View the latest CBAY earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 5,088.80. DOW 39,131.53. ...Feb 13, 2024 · Detailed statistics for CymaBay Therapeutics, Inc. (CBAY) stock, including valuation metrics, financial numbers, share information and more. ... Stock Price Statistics. The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has risen from $8.75 to $27.73 - a 216.91% increase. Ten analysts predict that CymaBay Therapeutics’s share price will increase in the coming year, reaching $32.50. This would represent an increase of 17.2%.Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing. Sep 9, 2023 ... ON THE VERGE OF BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK ... PRICE BREAKOUT : MFC STOCK ANALYSIS | MANULIFE FINANCIAL STOCK.The average one-year price target for CymaBay Therapeutics (NasdaqGS:CBAY) has been revised to 31.36 / share. This is an increase of 12.84% from the prior estimate of 27.80 dated January 16, 2024.CBAY ranks lowest in Stability; there it ranks in the 2nd percentile. CBAY Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CBAY is 0.1 -- better than just 13.13% of US stocks. With a price/sales ratio of 84.02, CYMABAY THERAPEUTICS INC has a higher such ratio than 97.51% of stocks in our set.Dec 5, 2022 ... ... cbay a good stock to buy, also is cbay a buy or sell? While analyzing cbay stock price target or doing the cbay stock review, it is ...3 days ago ... Latest CBAY News along with Price and Volume Analysis CBAY Stock Analysis $CBAY Latest News TickerDD. 1 view · 3 minutes ago ...more. TickerDD.Jan 30, 2024 · Headquarters. CymaBay Therapeutics 7575 Gateway Blvd Suite 110 Newark, CA 94560 T: (510) 293-88002 days ago · The Cymabay Therapeutics Inc stock price fell by -0.279% on the last day (Tuesday, 13th Feb 2024) from $32.21 to $32.12. During the last trading day the stock fluctuated 0.374% from a day low at $32.09 to a day high of $32.21. The price has risen in 6 of the last 10 days and is up by 35.81% over the past 2 weeks. Aug 2, 2023 · Fintel reports that on August 14, 2023, UBS initiated coverage of Cymabay Therapeutics (NASDAQ:CBAY) with a Buy recommendation.. Analyst Price Forecast Suggests 15.86% Upside. As of August 2, 2023 ...Interactive stock price chart for CymaBay Therapeutics, Inc. (CBAY) with real-time updates, full price history, technical analysis and more.The $32.50 price represents a nearly 27% premium from CymaBay's closing price on the trading day before the deal was announced but a more than 300% boost …Jan 14, 2024 · CBAY Historical Data. ... Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR ...Nasdaq. 15,942.59 +148.88 ... Shares of clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. CBAY gained after it announced positive top-line results from its late-stage RESPONSE study.View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN. CBAY has fallen -$0.10 from the previous closing price of $22.85 on volume of 483,390 shares. Over the past year the S&P 500 has gained 21.52% while CBAY has gained 191.67%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.Stock Price Statistics The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.Get CymaBay Therapeutics Inc (CBAY.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsThe latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by HC Wainwright & Co. on Friday, December 15, 2023. The analyst firm set a price target for 28.00 expecting CBAY to ...Feb 12, 2024 ... ... price Friday. CymaBay shares skyrocketed Monday to an all-time high after the news. Shares of CymaBay Therapeutics (CBAY) ...CymaBay Therapeutics Inc (CBAY) stock is lower by -2.32% while the S&P 500 is up 0.28% as of 9:53 AM on Monday, Dec 18. CBAY is lower by -$0.51 from the previous closing price of $22.03 on volume of 151,774 shares. Over the past year the S&P 500 has risen 23.96% while CBAY is up 384.68%. CBAY lost -$0.93 per share the over …Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Historical daily price data is available for up to two years prior to today's date. For more data, Barchart Premier members can download more historical data (going back to Jan. 1, 1980) and can download Intraday, Daily, Weekly, Monthly or Quarterly data on the Historical Data Download page. Additional underlying chart data and study values can ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...What's Happening With CBAY Stock Today? CymaBay Therapeutics Inc (CBAY) stock is trading at $24.65 as of 11:40 AM on Thursday, Dec 28, a gain of $0.18, or 0.74% from the previous closing price of $24.47. The stock has traded between $24.40 and $25.33 so far today. Volume today is light.Today, it's easy to get free stocks! In most cases, all you have to do is sign up for one of the investing apps on this list. Getting free stocks is simple - all you have to do is ...Cymabay Therapeutics (CBAY) Stock Price Performance. Cymabay Therapeutics (CBAY) Stock Key Data ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. The average twelve-month price prediction for CymaBay Therapeutics is $26.73 with a high price target of $32.50 and a low price target of $12.00. Learn more on ...When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks...Mar 28, 2023 · Shares of CymaBay Therapeutics Inc. (CBAY) have gained 11.4% over the past four weeks to close the last trading session at $8.73, but there could still be a solid upside left in the stock if short ...Get CymaBay Therapeutics Inc (CBAY.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsFeb 13, 2024 · Detailed statistics for CymaBay Therapeutics, Inc. (CBAY) stock, including valuation metrics, financial numbers, share information and more. ... Stock Price Statistics. The stock price has increased by +301.00% in the last 52 weeks. The beta is 0.28, so CBAY's price volatility has been lower than the market average.Feb 12, 2024 · Feb 12 (Reuters) - Gilead Sciences (GILD.O), opens new tab has agreed to buy CymaBay Therapeutics (CBAY.O), opens new tab for $4.3 billion, gaining access to an experimental liver disease ...When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks...Feb 14, 2024 ... MEGA BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK. 17 ... Price Action Trading like a Pro - I share my best tips after 14 years.Jun 30, 2023 ... The clinical-stage biotech saw its shares rise after Ipsen and Genfit announced phase 3 trials data for elafibranor to treat the rare autoimmune ...Jan 29, 2024 · Analyst Price Target for CBAY i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).CymaBay Therapeutics (CBAY) (Delayed Data from NSDQ) $32.18 USD -0.02 (-0.06%) Updated Feb 16, 2024 04:00 PM ET After-Market: $32.18 0.00 (0.00%) 7:58 …Historical daily price data is available for up to two years prior to today's date. For more data, Barchart Premier members can download more historical data (going back to Jan. 1, 1980) and can download Intraday, Daily, Weekly, Monthly or Quarterly data on the Historical Data Download page. Additional underlying chart data and study values can ...The exercise price per share for the stock options granted by CymaBay Therapeutics, Inc. is $32.18. How will the stock options vest for the employees at CymaBay ...CBAY is the ticker symbol for CymaBay Therapeutics Inc., a biotech company that develops treatments for rare liver diseases. The stock price, news, analysis, and …CBAY is the ticker symbol for CymaBay Therapeutics Inc., a biotech company that develops treatments for rare liver diseases. The stock price, news, analysis, and …What this means: CymaBay Therapeutics Inc. (CBAY) gets an Overall Rank of 68, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis. CBAY ranks lowest in Stability; there it ranks in the 2nd percentile. CBAY Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CBAY is 0.1 -- better than just 13.13% of US stocks. With a price/sales ratio of 84.02, CYMABAY THERAPEUTICS INC has a higher such ratio than 97.51% of stocks in our set.3 days ago · CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade ...CBAY enters Uptrend as Momentum indicator ascends above 0 level This indicator may be signaling that CBAY's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. CymaBay Therapeutics (CBAY) (Delayed Data from NSDQ) $32.18 USD -0.02 (-0.06%) Updated Feb 16, 2024 04:00 PM ET After-Market: $32.18 0.00 (0.00%) 7:58 …Feb 16, 2024 · CBAY, CymaBay Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target CBAY. High $ 36.00: Median $ 28.00: Low $ 20.00: Average $ 28.42: Current ... Aug 18, 2020 · Find the latest CymaBay Therapeutics, Inc. (CBAY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. ... Nasdaq 15,580.87-49.91 ...The company’s stock reached a 1-year high of $32.24 on 02/12/24, while the lowest price for the same period was registered at $7.26 on 06/27/23. 52-week price history of CBAY Stock. A stock’s 52-week high and low prices can reveal much about its current status and future trajectory.3 days ago · A. The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by LifeSci Capital on Wednesday, February 14, 2024. The analyst firm set a price target for 0.00 expecting CBAY to ... Feb 12, 2024 ... ... price Friday. CymaBay shares skyrocketed Monday to an all-time high after the news. Shares of CymaBay Therapeutics (CBAY) ...
CBAY ranks lowest in Stability; there it ranks in the 2nd percentile. CBAY Stock Summary. The capital turnover (annual revenue relative to shareholder's equity) for CBAY is 0.1 -- better than just 13.13% of US stocks. With a price/sales ratio of 84.02, CYMABAY THERAPEUTICS INC has a higher such ratio than 97.51% of stocks in our set.. How to convert pdf to excel
CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... Feb 13, 2024 · Cymabay Therapeutics 's market cap is calculated by multiplying CBAY's current stock price of $32.12 by CBAY's total outstanding shares of 113,403,353. CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has risen from $8.75 to $27.73 - a 216.91% increase. Ten analysts predict that CymaBay Therapeutics’s share price will increase in the coming year, reaching $32.50. This would represent an increase of 17.2%.This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday.What's Happening with CBAY Stock Today CymaBay Therapeutics Inc (CBAY) stock is up 2.44% while the S&P 500 has risen 0.75% as of 12:15 PM on Thursday, Dec 7. CBAY has risen $0.51 from the previous closing price of $20.86 on volume of 582,850 shares. Over the past year the S&P 500 has risen 16.51% while CBAY has risen …Jun 30, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is unmoved 0% while the S&P 500 is up 0.78% as of 4:00 PM on Thursday, Jun 29. CBAY is unmoved $0.00 from ...Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis.Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037CymaBay Therapeutics Inc (CBAY) Stock Price & News - Google Finance Home CBAY • NASDAQ CymaBay Therapeutics Inc Follow Share $32.18 After Hours: $32.13 (0.15%) -0.048 Closed: Feb 16, 4:54:20 PM... Feb 13, 2024 · CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The company’s shares closed last Monday at $32.21 ...CymaBay Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target CBAY. High $ 36.00: Median $ 28.00: Low $ 20.00: Average $ 28.42: Current ... According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since....